Three Months Ended March 31,
|
||||||||||||||||
GAAP
|
Non-GAAP(1)
|
|||||||||||||||
2023
|
2022
|
2023
|
2022
|
|||||||||||||
(dollars in thousands, except EPS)
|
||||||||||||||||
Revenue
|
$
|
74,256
|
$
|
42,186
|
$
|
74,256
|
$
|
42,186
|
||||||||
Gross margin
|
53.8
|
%
|
46.7
|
%
|
54.0
|
%
|
46.9
|
%
|
||||||||
Income (loss) from operations
|
$
|
8,862
|
$
|
(9,306
|
)
|
$
|
10,930
|
$
|
(7,932
|
)
|
||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
7,145
|
$
|
(5,786
|
)
|
$
|
9,867
|
$
|
(554
|
)
|
||||||
Basic EPS
|
$
|
0.12
|
$
|
(0.10
|
)
|
$
|
0.17
|
$
|
(0.01
|
)
|
||||||
Diluted EPS (2)(3)
|
$
|
0.11
|
$
|
(0.10
|
)
|
$
|
0.15
|
$
|
(0.01
|
)
|
(1) |
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial
Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized loss on trading securities.
|
(2) |
Prior period results have been adjusted to reflect the three-for-one stock split effected in the form of a stock dividend in March 2022.
|
(3) |
GAAP Diluted EPS for the first quarter of 2022 was incorrectly reported as ($0.09) on May 6, 2022.
|
• |
Shipments. Total shipments in the first quarter of 2023 were
$89.0 million, up 33.0% from the first quarter of 2022. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance
for potential revenue in future quarters.
|
• |
Received Purchase Order for SAPS Tool from Major European Global Semiconductor Manufacturer. In February 2023, ACM received a first tool order for its Ultra C SAPS-V cleaning tool from a major Europe-based global semiconductor manufacturer. The tool is expected to be shipped to the prospective customer’s
European facility in the fourth quarter of 2023.
|
• |
Received First Purchase Order for Ultra C SiC Substrate Cleaning Tool from Leading Chinese
Semiconductor Manufacturer. In March 2023, ACM received a purchase order for its Ultra C SiC substrate cleaning tool from a leading Chinese silicon carbide (SiC) substrate manufacturer. The platform
leverages ACM’s patented Space Alternated Phase Shift (SAPS) cleaning technology which is designed to achieve more comprehensive cleaning without damage to device features. The tool is expected to be shipped before the end of the third
quarter of 2023.
|
• |
Revenue was $74.3 million, up 76.0%, reflecting continued
share gains by our flagship cleaning products and incremental contribution from ECP, Furnace and other technologies, and Advanced packaging, services and spares.
|
• |
Gross margin was 53.8%, up from 46.7%. Non-GAAP gross
margin, which excludes stock-based compensation, was 54.0%, up from 46.9%. Gross margin exceeded the range of 40% to 45% reflected in the Company’s long-term business model due to favorable product mix. The Company expects gross margin to
vary from period to period due to a variety of factors, such as product mix, currency impacts and sales volume.
|
• |
Operating expenses were $31.1 million, an increase of 7.4%.
Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $29.2 million, up 5.2%. Operating expenses as a percent of revenue decreased to 41.9% from 68.7%. Non-GAAP operating expenses as a percent of
revenue decreased to 39.3% from 65.7%.
|
• |
Operating income was $8.9 million, compared to an operating loss of $9.3 million. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $10.9 million, compared to a non-GAAP
operating loss of $7.9 million.
|
• |
Unrealized loss on trading securities was $0.7 million. The
loss reflects the change in market value of the indirect investment by ACM Shanghai in the STAR Market IPO shares of Semiconductor Manufacturing International Corporation (“SMIC”). The
value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
|
• |
Realized gain from sale of trading securities was $4.0
million due to the sale of a portion of ACM Shanghai’s shares of SMIC, which generated net proceeds of $11.1 million.
|
• |
Income tax expense was $2.9 million, compared to an income
tax benefit of $4.0 million. As a result of a change in Section 174 of the U.S. Internal Revenue Code of 1986, as amended, that became effective on January 1, 2022, the Company’s effective tax rate has increased, due primarily to a new requirement to capitalize and amortize previously deductible research and experimental
expenses.
|
• |
Net income attributable to ACM Research, Inc. was $7.1
million, compared to a net loss of $5.8 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $9.9 million, as compared to a
non-GAAP net loss of $0.6 million.
|
• |
Net income per diluted share attributable to ACM Research, Inc. was $0.11, compared to a net loss of $0.10. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.15, compared to a non-GAAP net loss per
diluted share of $0.01.
|
• |
Cash and cash equivalents were $260.4 million at March 31,
2023, versus $248.0 million at December 31, 2022. Cash and cash equivalents, plus restricted cash and time deposits, were $381.7 million at March 31, 2023, versus
$420.9 million at December 31, 2022.
|
In the United States:
|
The Blueshirt Group
|
|
Yujia Zhai
|
||
+1 (860) 214-0809
|
||
yujia@blueshirtgroup.com
|
||
In China:
|
The Blueshirt Group Asia
|
|
Gary Dvorchak, CFA
|
||
+86 (138) 1079-1480
|
||
gary@blueshirtgroup.com
|
March 31, 2023
|
December 31, 2022
|
|||||||
(Unaudited)
|
||||||||
(In thousands, except for par value)
|
||||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
260,387
|
$
|
247,951
|
||||
Restricted cash
|
460
|
500
|
||||||
Short-term time deposits
|
2,999
|
70,492
|
||||||
Trading securities
|
12,733
|
20,209
|
||||||
Accounts receivable
|
186,130
|
182,936
|
||||||
Other receivables
|
36,178
|
29,617
|
||||||
Inventories
|
473,299
|
393,172
|
||||||
Advances to related party
|
2,306
|
3,322
|
||||||
Prepaid expenses
|
19,319
|
15,607
|
||||||
Total current assets
|
993,811
|
963,806
|
||||||
Property, plant and equipment, net
|
149,904
|
82,875
|
||||||
Land use right, net
|
8,761
|
8,692
|
||||||
Operating lease right-of-use assets, net
|
7,408
|
2,489
|
||||||
Intangible assets, net
|
1,233
|
1,255
|
||||||
Long-term time deposits
|
117,855
|
101,956
|
||||||
Deferred tax assets
|
13,035
|
6,703
|
||||||
Long-term investments
|
17,265
|
17,459
|
||||||
Other long-term assets
|
3,479
|
50,265
|
||||||
Total assets
|
$
|
1,312,751
|
$
|
1,235,500
|
||||
Liabilities and Equity
|
||||||||
Current liabilities:
|
||||||||
Short-term borrowings
|
$
|
56,745
|
$
|
56,004
|
||||
Current portion of long-term borrowings
|
2,369
|
2,322
|
||||||
Related party accounts payable
|
18,354
|
14,468
|
||||||
Accounts payable
|
116,558
|
101,735
|
||||||
Advances from customers
|
180,453
|
153,773
|
||||||
Deferred revenue
|
4,400
|
4,174
|
||||||
Income taxes payable
|
8,579
|
3,469
|
||||||
FIN-48 payable
|
6,774
|
6,686
|
||||||
Other payables and accrued expenses
|
52,966
|
52,201
|
||||||
Current portion of operating lease liability
|
3,013
|
1,382
|
||||||
Total current liabilities
|
450,211
|
396,214
|
||||||
Long-term borrowings
|
18,245
|
18,687
|
||||||
Long-term operating lease liability
|
4,395
|
1,107
|
||||||
Other long-term liabilities
|
7,195
|
7,321
|
||||||
Total liabilities
|
480,046
|
423,329
|
||||||
Commitments and contingencies
|
||||||||
Equity:
|
||||||||
Stockholders’ equity:
|
||||||||
Class A Common stock
|
5
|
5
|
||||||
Class B Common stock
|
1
|
1
|
||||||
Additional paid-in capital
|
606,398
|
604,089
|
||||||
Retained earnings
|
101,410
|
94,426
|
||||||
Statutory surplus reserve
|
16,881
|
16,881
|
||||||
Accumulated other comprehensive loss
|
(32,768
|
)
|
(40,546
|
)
|
||||
Total ACM Research, Inc. stockholders’ equity
|
691,927
|
674,856
|
||||||
Non-controlling interests
|
140,778
|
137,315
|
||||||
Total equity
|
832,705
|
812,171
|
||||||
Total liabilities and equity
|
$
|
1,312,751
|
$
|
1,235,500
|
Three Months Ended March 31,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
( In thousands, except share and per share data)
|
||||||||
Revenue
|
$
|
74,256
|
$
|
42,186
|
||||
Cost of revenue
|
34,270
|
22,500
|
||||||
Gross profit
|
39,986
|
19,686
|
||||||
Operating expenses:
|
||||||||
Sales and marketing
|
9,337
|
6,697
|
||||||
Research and development
|
14,029
|
17,346
|
||||||
General and administrative
|
7,758
|
4,949
|
||||||
Total operating expenses
|
31,124
|
28,992
|
||||||
Income from (loss) operations
|
8,862
|
(9,306
|
)
|
|||||
Interest income
|
1,785
|
1,805
|
||||||
Interest expense
|
(695
|
)
|
(261
|
)
|
||||
Realized gain from sale of trading securities
|
3,994
|
-
|
||||||
Unrealized loss on trading securities
|
(654
|
)
|
(3,858
|
)
|
||||
Other income (expense), net
|
(1,418
|
)
|
237
|
|||||
Equity loss in net loss of affiliates
|
(32
|
)
|
(71
|
)
|
||||
Income (loss) before income taxes
|
11,842
|
(11,454
|
)
|
|||||
Income tax benefit (expense)
|
(2,879
|
)
|
4,011
|
|||||
Net income (loss)
|
8,963
|
(7,443
|
)
|
|||||
Less: Net income (loss) attributable to non-controlling interests
|
1,818
|
(1,657
|
)
|
|||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
7,145
|
$
|
(5,786
|
)
|
|||
Comprehensive income (loss):
|
||||||||
Net income (loss)
|
8,963
|
(7,443
|
)
|
|||||
Foreign currency translation adjustment
|
9,423
|
2,454
|
||||||
Comprehensive Income (loss)
|
18,386
|
(4,989
|
)
|
|||||
Less: Comprehensive income (loss) attributable to non-controlling interests and redeemable non-controlling interests
|
3,462
|
(1,073
|
)
|
|||||
Comprehensive income (loss) attributable to ACM Research, Inc.
|
$
|
14,924
|
$
|
(3,916
|
)
|
|||
Net income (loss) attributable to ACM Research, Inc. per share of common stock:
|
||||||||
Basic
|
$
|
0.12
|
$
|
(0.10
|
)
|
|||
Diluted
|
$
|
0.11
|
$
|
(0.10
|
)
|
|||
Weighted average shares of common stock outstanding used in computing per share amounts:
|
||||||||
Basic
|
59,736,764
|
58,827,390
|
||||||
Diluted
|
65,058,777
|
58,827,390
|
`
|
Three Months Ended March 31,
|
|||||||
2023
|
2022
|
|||||||
|
($ in thousands)
|
|||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment
|
$
|
36,614
|
$
|
26,033
|
||||
ECP (front-end and packaging), furnace and other technologies
|
26,598
|
12,248
|
||||||
Advanced packaging (excluding ECP), services & spares
|
11,044
|
3,905
|
||||||
Total Revenue By Product Category
|
$
|
74,256
|
$
|
42,186
|
||||
Wet-cleaning and other front-end processing tools
|
$
|
56,382
|
$
|
31,702
|
||||
Advanced packaging, other processing tools, services and spares
|
17,874
|
10,484
|
||||||
Total Revenue Front-End and Back-End
|
$
|
74,256
|
$
|
42,186
|
||||
Three Months Ended March 31,
|
||||||||
2023
|
2022
|
|||||||
Mainland China
|
$
|
72,458
|
$
|
42,130
|
||||
Other Regions
|
1,798
|
56
|
||||||
Total Revenue By Region
|
$
|
74,256
|
$
|
42,186
|
Three Months Ended March 31,
|
||||||||||||||||||||||||||||||||
2023
|
2022
|
|||||||||||||||||||||||||||||||
Actual
|
SBC
|
Other non-operating adjustments
|
Adjusted
|
Actual
|
SBC
|
Other non-operating adjustments
|
Adjusted
|
|||||||||||||||||||||||||
(GAAP)
|
(Non-GAAP)
|
(GAAP)
|
(Non-GAAP)
|
|||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
Revenue
|
$
|
74,256
|
$
|
-
|
$
|
-
|
$
|
74,256
|
$
|
42,186
|
$
|
-
|
$
|
-
|
$
|
42,186
|
||||||||||||||||
Cost of revenue
|
(34,270
|
)
|
(125
|
)
|
-
|
(34,145
|
)
|
(22,500
|
)
|
(113
|
)
|
-
|
(22,387
|
)
|
||||||||||||||||||
Gross profit
|
39,986
|
(125
|
)
|
-
|
40,111
|
19,686
|
(113
|
)
|
-
|
19,799
|
||||||||||||||||||||||
Operating expenses:
|
||||||||||||||||||||||||||||||||
Sales and marketing
|
(9,337
|
)
|
(431
|
)
|
-
|
(8,906
|
)
|
(6,697
|
)
|
(354
|
)
|
-
|
(6,343
|
)
|
||||||||||||||||||
Research and development
|
(14,029
|
)
|
(701
|
)
|
-
|
(13,328
|
)
|
(17,346
|
)
|
(411
|
)
|
-
|
(16,935
|
)
|
||||||||||||||||||
General and administrative
|
(7,758
|
)
|
(811
|
)
|
-
|
(6,947
|
)
|
(4,949
|
)
|
(496
|
)
|
-
|
(4,453
|
)
|
||||||||||||||||||
Total operating expenses
|
(31,124
|
)
|
(1,943
|
)
|
-
|
(29,181
|
)
|
(28,992
|
)
|
(1,261
|
)
|
-
|
(27,731
|
)
|
||||||||||||||||||
Income (loss) from operations
|
$
|
8,862
|
$
|
(2,068
|
)
|
$
|
-
|
$
|
10,930
|
$
|
(9,306
|
)
|
$
|
(1,374
|
)
|
$
|
-
|
$
|
(7,932
|
)
|
||||||||||||
Unrealized loss on trading securities
|
(654
|
)
|
-
|
(654
|
)
|
-
|
(3,858
|
)
|
-
|
(3,858
|
)
|
-
|
||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc.
|
$
|
7,145
|
$
|
(2,068
|
)
|
$
|
(654
|
)
|
$
|
9,867
|
$
|
(5,786
|
)
|
$
|
(1,374
|
)
|
$
|
(3,858
|
)
|
$
|
(554
|
)
|
||||||||||
Basic EPS
|
$
|
0.12
|
$
|
0.17
|
$
|
(0.10
|
)
|
$
|
(0.01
|
)
|
||||||||||||||||||||||
Diluted EPS
|
$
|
0.11
|
$
|
0.15
|
$
|
(0.10
|
)
|
$
|
(0.01
|
)
|